Immunotherapy in Corticotroph and Lactotroph Aggressive Tumors and Carcinomas: Two Case Reports and a Review of the Literature

Immunotherapy in Corticotroph and Lactotroph Aggressive Tumors and Carcinomas: Two Case Reports and a Review of the Literature

Once temozolomide has failed, no other treatment is recommended for pituitary carcinomas and aggressive pituitary tumors. Recently, the use of immune checkpoint inhibitors (ICIs) has raised hope, but so far, only one corticotroph carcinoma and one aggressive corticotroph tumor treated with immunothe...

Full description

Bibliographic Details
Main Authors: Camille Duhamel, Mirela Diana Ilie, Henri Salle, Adjoa Sika Nassouri, Stephan Gaillard, Elise Deluche, Richard Assaker, Laurent Mortier, Christine Cortet, Gérald Raverot
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Journal of Personalized Medicine
Subjects:
immune checkpoint inhibitors (ICIs)
ipilimumab
nivolumab
prolactinoma
Cushing’s disease
aggressive pituitary tumor
Online Access:https://www.mdpi.com/2075-4426/10/3/88

Internet

https://www.mdpi.com/2075-4426/10/3/88

Similar Items